📊 Analyst Consensus & Targets
- Analyst Rating: Hold
- Price Target: $55.08696
- Sector: Healthcare – Drug Manufacturers – General
💡 The Growth Thesis
Hold Consensus: Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. Analysts project a 2.1% potential upside. Currently trading at a Forward P/E of 8.996732.